Research output per year
Research output per year
Research output
- 1 - 50 out of 84 results
Search results
-
2025
Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
Ehlers, F. A. I., Blise, K. E., Betts, C. B., Sivagnanam, S., Kooreman, L. F. S., Hwang, E. S., Bos, G. M. J., Wieten, L. & Coussens, L. M., 24 Jan 2025, In: Breast Cancer Research. 27, 1, 17 p., 14.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
2024
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial
Mai, E. K., Nogai, A., Lokhorst, H. M., van der Holt, B., Zweegman, S., Weisel, K. C., Croockewit, S., Jauch, A., Hillengass, J., Stevens-Kroef, M., Raab, M. S., Broijl, A., Bos, G. M. J., Brossart, P., Ypma, P., Hanoun, C., Bertsch, U., Hielscher, T., Salwender, H. J. & Scheid, C. & 2 others, , 1 Nov 2024, In: HemaSphere. 8, 11, 5 p., e70052.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open Access -
HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma
Beelen, N. A., Molenbroeck, S. J. J., Groeneveld, L., Voorter, C. E., Bos, G. M. J. & Wieten, L., Jun 2024, In: Immunogenetics. 76, 3, p. 155-164 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients
Minnema, M. C., Nasserinejad, K., Hegenbart, U., Ypma, P. F., Wu, K. L., Kersten, M. J., Croockewit, S., Zweegman, S., Tick, L., Broijl, A., Koene, H., Bos, G. M. J., Sonneveld, P. & Schonland, S. O., Aug 2024, In: eJHaem. 5, 4, p. 815-819 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
Beelen, N. A., Valckx, V. T. C., Bos, G. M. J. & Wieten, L., 1 Sept 2024, In: Best Practice & Research Clinical Haematology. 37, 3, 10 p., 101568.Research output: Contribution to journal › Article › Academic › peer-review
-
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Gong, Y., Germeraad, W. T. V., Zhang, X., Wu, N., Li, B., Janssen, L., He, Z., Gijbels, M. J. J., Wu, B., Gijsbers, B. L. M. G., Olieslagers, T. I., Bos, G. M. J., Zheng, L. & Klein Wolterink, R. G. J., 7 Aug 2024, In: Molecular Therapy. 32, 8, p. 2711-2727 17 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
2023
An in vitro model to monitor natural killer cell effector functions against breast cancer cells derived from human tumor tissue
Beelen, N. A., Ehlers, F. A. I., Kooreman, L. F. S., Bos, G. M. J. & Wieten, L., Jan 2023, The Immunological Synapse Part A. Thomas, C. & Galluzzi, L. (eds.). 1 ed. Academic Press, Vol. 173. p. 133-153 21 p. (Methods in Cell Biology).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic
-
Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids
Beelen, N. A., Aberle, M. R., Bruno, V., Olde Damink, S. W. M., Bos, G. M. J., Rensen, S. S. & Wieten, L., 14 Jul 2023, In: Frontiers in Immunology. 14, 1, 16 p., 1133796.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages
Ehlers, F. A. I., Mahaweni, N. M., van de Waterweg Berends, A., Saya, T., Bos, G. M. J. & Wieten, L., Jun 2023, In: Cancer Immunology Immunotherapy. 72, 6, p. 1789-1801 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Beelen, N. A., Ehlers, F. A. I., Bos, G. M. J. & Wieten, L., Apr 2023, In: Cancer Immunology Immunotherapy. 72, 4, p. 797-804 8 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma
Verkleij, C. P. M., Frerichs, K. A., Broekmans, M. E. C., Duetz, C., O'Neill, C. A., Bruins, W. S. C., Homan-Weert, P. M., Minnema, M. C., Levin, M. D., Broijl, A., Bos, G. M. J., Kersten, M. J., Klein, S. K., Shikhagaie, M. M., Casneuf, T., Abraham, Y., Smets, T., Vanhoof, G., Cortes-Selva, D. & van Steenbergen, L. & 7 others, , 2 May 2023, In: HemaSphere. 7, 5, 15 p., e881.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
2022
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Sonneveld, P., Zweegman, S., Cavo, M., Nasserinejad, K., Broijl, A., Troia, R., Pour, L., Croockewit, S., Corradini, P., Patriarca, F., Wu, K., Droogendijk, J., Bos, G., Hajek, R., Teresa Petrucci, M., Ypma, P., Zojer, N., Minnema, M. C. & Boccadoro, M., 30 Oct 2022, In: HemaSphere. 6, 10, 8 p., e786.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Easy-to-Use HPLC Method to Measure Intracellular Ascorbic Acid Levels in Human Peripheral Blood Mononuclear Cells and in Plasma
van Gorkom, G., Gijsbers, B., Ververs, E. J., El Molla, A., Sarodnik, C., Riess, C., Wodzig, W., Bos, G. & Van Elssen, C., 1 Jan 2022, In: Antioxidants. 11, 1, 12 p., 134.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial
van Gorkom, G. N. Y., Boerenkamp, L. S., Gijsbers, B. L. M. G., van Ojik, H. H., Wodzig, W. K. W. H., Wieten, L., Van Elssen, C. H. M. J. & Bos, G. M. J., 11 Nov 2022, In: Nutrients. 14, 22, 15 p., 4784.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5
Ehlers, F. A. I., Olieslagers, T. I., Groeneweg, M., Bos, G. M. J., Tilanus, M. G. J., Voorter, C. E. M. & Wieten, L., Sept 2022, In: HLA. 100, 3, p. 232-243 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands
van Gorkom, G., Van Elssen, C., Janssen, I., Groothuis, S., Evers, S. & Bos, G., Apr 2022, In: European Journal of Haematology. 108, 4, p. 327-335 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
2021
Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients
Ehlers, F. A. I., Mahaweni, N. M., Olieslagers, T. I., Bos, G. M. J. & Wieten, L., 20 May 2021, In: Frontiers in Oncology. 11, 9 p., 622896.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
Ehlers, F. A., Beelen, N. A., van Gelder, M., Evers, T. M. J., Smidt, M. L., Kooreman, L. F. S., Bos, G. M. J. & Wieten, L., Jul 2021, In: Cancers. 13, 13, 18 p., 3232.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong, Y., Wolterink, R. G. J. K., Wang, J. X., Bos, G. M. J. & Germeraad, W. T. V., 1 May 2021, In: Journal of Hematology & Oncology. 14, 1, 35 p., 73.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
Sonneveld, P., Dimopoulos, M. A., Beksac, M., van der Holt, B., Aquino, S., Ludwig, H., Zweegman, S., Zander, T., Zamagni, E., Wester, R., Hajek, R., Pantani, L., Dozza, L., Gay, F., Cafro, A., De Rosa, L., Morelli, A., Gregersen, H., Gulbrandsen, N. & Cornelisse, P. & 20 others, , 10 Nov 2021, In: Journal of Clinical Oncology. 39, 32, p. 3613-3622 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
Gong, Y., Klein Wolterink, R. G. J., Gulaia, V., Cloosen, S., Ehlers, F. A. I., Wieten, L., Graus, Y. F., Bos, G. M. J. & Germeraad, W. T. V., Jun 2021, In: Cancers. 13, 11, 19 p., 2579.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
Frerichs, K. A., Minnema, M. C., Levin, M. D., Broijl, A., Bos, G. M. J., Kersten, M. J., Mutis, T., Verkleij, C. P. M., Nijhof, I. S., Maas-Bosman, P. W. C., Klein, S. K., Zweegman, S., Sonneveld, P. & van de Donk, N. W. C. J., 14 Dec 2021, In: Blood advances. 5, 23, p. 5128-5139 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
Van Elssen, C., van Gorkom, G., Voorter, C., von Dem Borne, P., Meijer, E., Wieten, L. & Bos, G., Jan 2021, In: Annals of Hematology. 100, 1, p. 181-187 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Real-world experience: Introduction of T cell replete haploidentical transplantations in a single center
van Gorkom, G., Billen, E., Van Elssen, C., van Gelder, M. & Bos, G., Aug 2021, In: eJHaem. 2, 3, p. 440-448 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
The Next Step Toward Patient-Centeredness in Multidisciplinary Cancer Team Meetings: An Interview Study with Professionals
Geerts, P. A. F., van der Weijden, T., Savelberg, W., Altan, M., Chisari, G., Launert, D. R., Mesters, H., Pisters, Y., van Heumen, M., Hermanns, R., Bos, G. M. J. & Moser, A., 2021, In: Journal of Multidisciplinary Healthcare. 14, p. 1311-1324 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
2020
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Cavo, M., Gay, F., Beksac, M., Pantani, L., Petrucci, M. T., Dimopoulos, M. A., Dozza, L., van der Holt, B., Zweegman, S., Oliva, S., van der Velden, V. H. J., Zamagni, E., Palumbo, G. A., Patriarca, F., Montefusco, V., Galli, M., Maisnar, V., Gamberi, B., Hansson, M. & Belotti, A. & 30 others, , 1 Jun 2020, In: The Lancet Haematology. 7, 6, p. E456-E468 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Nielsen, L. K., Stege, C., Lissenberg-Witte, B., van der Holt, B., Mellqvist, U.-H., Salomo, M., Bos, G., Levin, M.-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Coenen, J., Hinge, M., Klein, S., Tanis, B., Szatkowski, D., Brouwer, R., Westerman, M. & Leys, R. & 10 others, , Jun 2020, In: Haematologica-the Hematology Journal. 105, 6, p. 1650-1659 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
Gong, Y., Wolterink, R. G. J. K., Janssen, I., Groot, A. J., Bos, G. M. J. & Germeraad, W. T. V., 12 Jun 2020, In: Molecular Therapy - Methods and Clinical Development. 17, p. 634-646 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
The Perception of Shared Decision-Making in Hematology by Patients and Physicians Seems Satisfactory, but Important Steps are Still Ahead of Us
Geerts, P. A. F., van der Weijden, T., Moser, A. & Bos, G. M. J., 1 Aug 2020, In: HemaSphere. 4, 4, 4 p., e417.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open Access -
2019
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
Minnema, M. C., Nasserinejad, K., Hazenberg, B., Hegenbart, U., Vlummens, P., Ypma, P. F., Kroeger, N., Wu, K. L., Kersten, M. J., Schaafsma, M. R., Croockewit, S., de Waal, E., Zweegman, S., Tick, L., Broijl, A., Koene, H., Bos, G., Sonneveld, P. & Schoenland, S., 30 Oct 2019, In: Haematologica-the Hematology Journal. 104, 11, p. 2274-2282 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Characterization of BAT activity in rats using invasive and non-invasive techniques
Paulus, A., van Ewijk, P. A., Nascimento, E. B. M., De Saint-Hubert, M., Hendrikx, G., Vogg, A., Pooters, I., Schnijderberg, M., Vanderlocht, J., Bos, G., Brans, B., Schrauwen-Hinderling, V. B., Mottaghy, F. M. & Bauwens, M., 15 May 2019, In: PLOS ONE. 14, 5, p. 1-18 18 p., e0215852.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs
Geerts, P. A. F., van der Weijden, T., Loeffen, P. G. M., Janssen, L. E. F., Almekinders, C., Wienhold, T. A. & Bos, G. M. J., 11 Jul 2019, In: BMC Medical Informatics and Decision Making. 19, 10 p., 129.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Maastricht introduceert een allesomvattende beoordeling: Na het opleidingsmodel heeft Maastricht nu ook het beoordelen van studenten vernieuwd
Beckers, H., Bos, G., Rennenberg, R. & Govaerts, M., 19 Sept 2019, In: Medisch Contact. 38, p. 34-37Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile54 Downloads (Pure) -
The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review
van Gorkom, G. N. Y., Lookermans, E. L., Van Elssen, C. H. M. J. & Bos, G. M. J., May 2019, In: Nutrients. 11, 5, 15 p., 977.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2018
A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism
Mahaweni, N. M., Olieslagers, T. I., Rivas, I. O., Molenbroeck, S. J. J., Groeneweg, M., Bos, G. M. J., Tilanus, M. G. J., Voorter, C. E. M. & Wieten, L., 29 Oct 2018, In: Scientific Reports. 8, 1, 11 p., 15983.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial
Goldschmidt, H., Lokhorst, H. M., Mai, E. K., van der Holt, B., Blau, I. W., Zweegman, S., Weisel, K. C., Vellenga, E., Pfreundschuh, M., Kersten, M. J., Scheid, C., Croockewit, S., Raymakers, R., Hose, D., Potamianou, A., Jauch, A., Hillengass, J., Stevens-Kroef, M., Raab, M. S. & Broijl, A. & 12 others, , 1 Feb 2018, In: Leukemia. 32, 2, p. 383-390 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients
Franssen, L. E., Nijhof, I. S., Couto, S., Levin, M.-D., Bos, G. M. J., Broijl, A., Klein, S. K., Ren, Y., Wang, M., Koene, H. R., Bloem, A. C., Beeker, A., Faber, L. M., van der Spek, E., Raymakers, R., Leguit, R. J., Sonneveld, P., Zweegman, S., Lokhorst, H. & Mutis, T. & 3 others, , 31 Jul 2018, In: Haematologica-the Hematology Journal. 103, 8, p. E368-E371 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open Access -
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions
Mahaweni, N. M., Bos, G. M. J., Mitsiades, C. S., Tilanus, M. G. J. & Wieten, L., 1 Jun 2018, In: Cancer Immunology Immunotherapy. 67, 6, p. 861-872 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Influence of Vitamin C on Lymphocytes: An Overview
van Gorkom, G. N. Y., Wolterink, R. G. J. K., Van Elssen, C. H. M. J., Wieten, L., Germeraad, W. T. V. & Bos, G. M. J., 10 Mar 2018, In: Antioxidants. 7, 3, 14 p., 41.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
Franssen, L. E., Nijhof, I. S., Bjorklund, C. C., Chiu, H., Doorn, R., Van Velzen, J., Emmelot, M., Van Kessel, B., Levin, M. D., Bos, G. M. J., Broijl, A., Klein, S. K., Koene, H. R., Bloem, A. C., Beeker, A., Faber, L. M., Van Der Spek, E., Raymakers, R., Sonneveld, P. & Zweegman, S. & 5 others, , 1 Sept 2018, In: Oncotarget. 9, 74, p. 34009-34021 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
Mahaweni, N. M., Ehlers, F. A., Sarkar, S., Janssen, J. W. H., Tilanus, M. G. J., Bos, G. M. J. & Wieten, L., 22 Jun 2018, In: Frontiers in Immunology. 9, JUN, 12 p., 1415.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-γ
Oth, T., Habets, T. H. P. M., Germeraad, W. T. V., Zonneveld, M. I., Bos, G. M. J. & Vanderlocht, J., 13 Feb 2018, In: BMC IMMUNOLOGY. 19, 1, 13 p., 8.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial
van de Donk, N. W. C. J., van der Holt, B., Minnema, M. C., Vellenga, E., Croockewit, S., Kersten, M. J., von dem Borne, P. A., Ypma, P., Schaafsma, R., de Weerdt, O., Klein, S. K., Delforge, M., Levin, M.-D., Bos, G. M., Jie, K.-S. G., Sinnige, H., Coenen, J. L. L. M., de Waal, E. G., Zweegman, S. & Sonneveld, P. & 1 others, , 1 Oct 2018, In: The Lancet Haematology. 5, 10, p. E479-E492 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppression
Habets, T. H. P. M., Vanderlocht, J., Straat, R. J. M. H. E., van Smaalen, T. C., Bos, G. M. J., Beckers, E. A., Christiaans, M. H. L. & Henskens, Y. M. C., 1 Jan 2018, In: Transfusion. 58, 1, p. 100-104 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression
Habets, T. H. P. M., Hepkema, B. G., Kouprie, N., Schnijderberg, M. C. A., van Smaalen, T. C., Bungener, L. B., Christiaans, M. H. L., Bos, G. M. J. & Vanderlocht, J., 7 Sept 2018, In: PLOS ONE. 13, 9, 19 p., e0203381.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
Mahaweni, N. M., Ehlers, F. A. I., Bos, G. M. J. & Wieten, L., 4 Dec 2018, In: Frontiers in Immunology. 9, 8 p., 2848.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2017
Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
van Gelder, M., Vanclee, A., van Elssen, C. H. M. J., Hupperets, P., Wieten, L. & Bos, G. M., Feb 2017, In: Breast Cancer Research and Treatment. 161, 3, p. 421-433 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Permitting patients to pay for participation in clinical trials: the advent of the P4 trial
Shaw, D., de Wert, G., Dondorp, W., Townend, D., Bos, G. & van Gelder, M., Jun 2017, In: Medicine Health Care and Philosophy. 20, 2, p. 219-227 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
Dolstra, H., Roeven, M. W. H., Spanholtz, J., Hangalapura, B. N., Tordoir, M., Maas, F., Leenders, M., Bohme, F., Kok, N., Trilsbeek, C., Paardekooper, J., van der Waart, A. B., Westerweel, P. E., Snijders, T. J. F., Cornelissen, J., Bos, G., Pruijt, H. F. M., de Graaf, A. O., van der Reijden, B. A. & Jansen, J. H. & 6 others, , 1 Aug 2017, In: Clinical Cancer Research. 23, 15, p. 4107-4118 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
‘Revival’ van de haplo-identieke stamceltransplantatie
Translated title of the contribution :R evival of the haploidentical stem cell transplantation Research output: Contribution to journal › Article › Academic › peer-review